top of page

SELECTED PEER REVIEWED BOOKS & ARTICLES

​

  • Helena Hansen, Jules Netherland, David Herzberg, Whiteout: How Racial Capitalism Changed the Color of America's Opioid Crises (University of California Press, forthcoming 2023)

  • David Herzberg, White Market Drugs: Addictive Pharmaceuticals and American Drug Policy (University of Chicago Press, 2020)

  • David Herzberg, Happy Pills in America: From Miltown to Prozac (Baltimore: Johns Hopkins University Press, 2009)

  • Nils Kessel, Joseph Gabriel, and David Herzberg, eds., Risk/Benefit: Histories from the Borderlands between Medicines and Drugs (under review)

​

  • Anne Kveim Lie, Helena Hansen, David Herzberg, Alex Mold, Marie Jauffret-Roustide, Isa Dussauge, Samuel K. Roberts, Jeremy Greene, and Nancy Campbell, “The harms of constructing addiction as a chronic, relapsing brain disease,” American Journal of Public Health 112(52), Supp 2, 2022, S104-S108, link

  • David Herzberg and Jeremy Greene, “Stuck in Traffic? Conflicting regimes of global pharmaceutical governance,” Diplomatic History 45(5), November 2021, 940-953, link.

  • Danielle Fine, David Herzberg, and Sarah Wakeman, “Societal Biases, Institutional Discrimination, and Trends in Opioid Use in the USA,” Journal of General Internal Medicine 36 (2021), 797-801, link.

  • David Herzberg, “Between the Free Market and the Drug War,” in David Farber, ed., The War on Drugs: A History: Fifty Years, a Trillion Dollars, and Thirty Million Arrests (New York University Press, 2021).

  • David Herzberg, Dorian Deshauer, and Matt Savelli, “Psychopharmaceuticals” in Mat Savelli, James Gillett, and Gavin J. Andrews, Eds., An Introduction to Mental Health and Illness: Critical Perspectives (Oxford University Press, 2020).

  • Scott Podolsky, David Herzberg, and Jeremy Greene, “Preying on Prescribers (and Their Patients): Pharmaceutical Marketing, Iatrogenic Epidemics, and the Sackler Legacy,” New England Journal of Medicine, April 10, 2019, 1-3 link

  • David Herzberg, “Entitled to Addiction? Race and pharmaceuticals in America’s first drug war,” Bulletin of the History of Medicine 91 (Fall 2017), 586-623- winner J. Worth Estes Prize 2018 link

  • Nancy D. Campbell and David Herzberhg, "Gender and Critical Drug Studies: An Introduction and an Invitation," Contemporary Drug Problems 44(4), November 16, 2017 and Social History of Alcohol and Drugs 31, 2017 link

  • David Herzberg, Honoria Guarino, Pedro Mateu-Gelabert, and Alex S. Bennett, "Recurring Epidemics of Pharmaceutical Drug Abuse in America: Time for an All-Drug Strategy," American Journal of Public Health, March 2016: 408-10 link

  • David Herzberg, "Pills" in Rethinking Therapeutic Culture, eds. Timothy Aubrey and Trysh Travis (University of Chicago Press, 2015)

  • David Herzberg, "Busted for Blockbusters: 'Scrip Mills' and Prescribing Power in the 1970s," in Jeremy Greene and Elizabeth Segal Watkins, eds., Prescribed: Writing, Filling, Using, and Abusing the Prescription in Modern America (Johns Hopkins University Press, 2012).

  • David Herzberg, "Blockbusters and Controlled Substances: Miltown, Quaalude, and Consumer Demand for Drugs in Postwar America," Cambridge Studies in the History and Philosophy of the Biological Sciences 42(4), December 2011: 415-26, link.

  • Jeremy Greene and David Herzberg, "Hidden in Plain Sight: The Popular Promotion of Prescription Drugs in the 20th  Century," American Journal of Public Health (May 2010): 793-803- winner article of year AJPH 2011 link

  • David Herzberg, "'Will Wonder Drugs Never Cease!': A Prehistory of Direct-to-Consumer Advertising," Pharmacy in History 51(2), 2009, p. 47-56

  • David Herzberg, "'The Pill You Love Can Turn On You': Feminism, Tranquilizers, and the Valium Panic of the 1970s." American Quarterly (March 2006): 79-103.​

SELECTED OTHER WRITINGS

​​

  • “The opioid crisis isn’t just the Sacklers’ fault—and making Purdue Pharma pay isn’t enough on its own to fix the pharmaceutical industry’s deeper problems,” The Conversation, July 26, 2021, link

  • “Early U.S. drug regimes and medical and drug cultures,” Oxford University Press Companion to Drug History (Paul Gootenberg, ed.), 2022.​

  • “From one extreme to the other? The political construction of opioid consensus in the U.S.’s long 20th century,” Les Cahiers Droit Sciences et Technologies: Le consensus en droit de la santé et en droit de l’environnement [special issue on “consensus in health and environment"], December 2021, 119-136.

  • Review of Sam Quinones, The Least of Us: True Tales of America and Hope in the Time of Fentanyl and Meth (Bloomsbury, 2021), Washington Post, November 26, 2021 link,

  • Review of Michael Pollan, This Is Your Brain on Plants (Penguin, 2021); Washington Post, July 23, 2021 link,

  • “The company that makes OxyContin could become a ‘public trust’—what would that mean?” The Conversation, December 4, 2019; reprinted in Salon, The National Interest, San Francisco Chronicle, Houston Chronicle, and other places, link.

  • Helena Hansen, Jules Netherland, and David Herzberg, “How race made the opioid crisis,” Boston Review, April 9, 2019, link.

  • David Herzberg and Matt Pembleton, “While government cracked down on illegal drugs, Big Pharma hooked millions on opioids: The racist roots of the opioid crisis,” Washington Post, October 30, 2017, link.

  • "Setting today's opioid epidemic in historical context," Process: A Blog for American History (OAH), March 27, 2017

  • “Drug war dissents: Robinson v. California,” Points: The Blog of the Alcohol and Drug History Society, June 7, 2016

  • “100 words on the Harrison Act at 100,” Points: The Blog of the Alcohol and Drug History Society, December 17, 2014

  • “Shadow Journals: The Story of Medical Advertising,” 3-part blog post for the New York Academy of Medicine, October 15, 17, 19, 2013

  • Review of Joseph E. Davis. Chemically Imbalanced: Everyday Suffering, Medication, and Our Troubled Quest for Self-Mastery; Bulletin of the History of Medicine (Fall 2021)

  • Review of Keith Wailoo, Pain: A Political History and Joanna Bourke, The Story of Pain: From Prayer to Painkillers; Journal of the History of Medicine and Allied Sciences 71:2 (2016): 242-6

  • Review of Nassir Ghaemi, Drugs, Diagnosis, and Despair in the Modern World; Bulletin of the History of Medicine 89:3 (Fall 2015), 628-9

bottom of page